- Report
- April 2022
- 139 Pages
Global
From €1771EUR$2,000USD£1,534GBP
- Report
- November 2021
- 113 Pages
Global
From €3099EUR$3,500USD£2,684GBP
- Drug Pipelines
- July 2020
- 41 Pages
Global
From €3099EUR$3,500USD£2,684GBP
- Drug Pipelines
- April 2019
- 85 Pages
Global
From €3099EUR$3,500USD£2,684GBP
- Drug Pipelines
- November 2018
- 39 Pages
Global
From €3099EUR$3,500USD£2,684GBP
- Report
- August 2023
- 80 Pages
Russia
From €1328EUR$1,500USD£1,150GBP
- Report
- August 2023
- 80 Pages
Poland
From €1328EUR$1,500USD£1,150GBP
- Report
- August 2023
- 100 Pages
Africa
From €1771EUR$2,000USD£1,534GBP
- Report
- August 2023
- 80 Pages
Russia
From €1328EUR$1,500USD£1,150GBP
- Report
- August 2023
- 80 Pages
Poland
From €1328EUR$1,500USD£1,150GBP
- Report
- August 2023
- 100 Pages
Africa
From €1771EUR$2,000USD£1,534GBP
- Report
- June 2025
- 416 Pages
United States
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 132 Pages
Mexico
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 133 Pages
Brazil
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 190 Pages
United Kingdom
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 135 Pages
Russia
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 150 Pages
Spain
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 138 Pages
Italy
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 153 Pages
France
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 142 Pages
South Korea
From €4422EUR$4,995USD£3,830GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more